Mon, Jan 26, 2015, 3:42 PM EST - U.S. Markets close in 18 mins.


% | $
Quotes you view appear here for quick access.

Brocade Communications Systems, Inc. Message Board

pharmaapproved 266 posts  |  Last Activity: Jan 23, 2015 8:15 AM Member since: Jun 7, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    UCLA Surgeon's Excellent & Balanced Review of VBLOC

    by dctrig Jan 22, 2015 4:30 PM
    pharmaapproved pharmaapproved Jan 23, 2015 8:15 AM Flag

    Adam's no dummy. He knows Doctors will be performing this procedure, and if he doesn't know then he should do some better dd. I have come across 10 Doctors/surgeons or so in the past week who are excited and look forward to being able to offer their patients this new alternative. Sure beats having you guts ripped apart or altered! And if you read the comments section of each article that has came out recently there are many people saying how they want to have this done. As soon as there is confirmation of just a handful of procedures being done I think the pps will take off.

  • Reply to

    I HAD to sell

    by tiktokstock Jan 22, 2015 6:34 PM
    pharmaapproved pharmaapproved Jan 22, 2015 7:11 PM Flag

    That suxx, but good luck and I hope things start looking up for you and your family!

  • Reply to

    UCLA Surgeon's Excellent & Balanced Review of VBLOC

    by dctrig Jan 22, 2015 4:30 PM
    pharmaapproved pharmaapproved Jan 22, 2015 6:57 PM Flag

    Wow, that is pretty impressive commentary. He worked in France where they talked about this device which they where very excited about. Now back in the U.S. Surgeons are hearing about it now that FDA approval has come. And although UCLA has not been visited by the company yet it sounds like they are waiting to be as they look forward to this ground breaking technology. These are the stories we need to hear, and will surly start hearing more in the coming months. This is one of if not the best interview i have come across. Thanks for sharing your dd!! I am posting the link because I had a little trouble finding it, but all credit is yours for a great find! Good Luck!!


  • Reply to

    So investors don't get it

    by rpk82181 Jan 22, 2015 9:59 AM
    pharmaapproved pharmaapproved Jan 22, 2015 11:32 AM Flag

    I have my own theory like yours but it will probably happen in the lower range of what I was expecting. If my theory doesn't pan out I don't know why anyone at this level wouldn't give Brad Hancock the opportunity do what he seems really good at. He has already "Successfully launched a new Spinal Cord Stimulator, Deep Brain Stimulator, and Programmable Pump. which Exceeded operating profit and maintained margins during tenure at Medtronic" That's a hell of a resume!!

    The problem with the stock price is not company specific imo. I believe there where a "BOATLOAD OF FAST MONEY TRADERS" on this who had no idea the atm was already in place.

  • Reply to

    Labeling Published on FDA Site

    by biotia Jan 21, 2015 9:37 AM
    pharmaapproved pharmaapproved Jan 21, 2015 1:45 PM Flag

    We are beyond all this, the FDA already approved it. Also, don't lose sight of the 36-month Diabetes, Hypertension and Weight Loss Data


  • Reply to

    Labeling Published on FDA Site

    by biotia Jan 21, 2015 9:37 AM
    pharmaapproved pharmaapproved Jan 21, 2015 12:15 PM Flag

    The 18 month data is what matters and is what the FDA was most likely looking at.

    Efficacy through 18 months was assessed using three statistical techniques: a mixed effects regression model, the LOCF methodology, as well as without imputation. Results from the mixed-effects model suggest that weight loss with VBLOC therapy was durable, with an estimated mean 25.8% EWL at 12 months, 24.4% at 15 months, and 23.5% EWL at 18 months. The sham control group regained a significant amount of weight following the 12-month visit, with an estimated mean % EWL of 16.9% at 12 months, 12.9% at 15 months, and 10.1% at 18 months. The treatment difference increased from 8.9 percentage points (95% CI: 4.3 to 13.5) at 12 months to 13.4 percentage points (95% CI: 8.4 to 18.4) at 18 months. This increase in relative efficacy as a result of the sham control group gaining weight cannot be largely attributed to unblinding since most subjects remained blinded until the 16-month visit.

  • Reply to

    new video news clip...very

    by ides1948 Jan 21, 2015 10:59 AM
    pharmaapproved pharmaapproved Jan 21, 2015 11:13 AM Flag

    Thanks for posting. Doctors are excited and that's all that matters for now. Remember, it's not going to take much of a sales force to launch this. Doctors like this guy will be doing a majority of the selling for us. So never mind the price swings for now, it's a shakeout to create doubt and uncertainty. Stick to the facts as you know them. The facts point to what is going to be a widely accepted new device to combat the "MULTI-BILLION DOLLAR" obesity epidemic. I know it doesn't appear that way today, but it will!

  • Reply to

    Labeling Published on FDA Site

    by biotia Jan 21, 2015 9:37 AM
    pharmaapproved pharmaapproved Jan 21, 2015 10:07 AM Flag

    And to those who said people of color, and gender would be excluded. Read it, and weep boys & girls!


  • Reply to

    Interesting Article

    by innsbrooklad Jan 21, 2015 7:12 AM
    pharmaapproved pharmaapproved Jan 21, 2015 9:58 AM Flag

    Johns Hopkins: Expert Panel Concludes: Neurostimulation Can Be Life-Changing Therapy for Obesity, Alzheimer’s and Chronic Pain

    The International Neuromodulation Society selected members of the international scientific community to analyze scientific evidence for current and future innovations related to neurostimulation and to use clinical experience to fill in any gaps in information. The experts determined that currently approved neurostimulation techniques and technologies have expanded physicians’ ability to treat patients in a more effective and specific fashion. However, there are several additional promising technologies and potential applications for neurostimulation that could move this field forward and expand its applicability. For example, neurostimulation therapy may be able to help treat a number of nonpain states, including obesity, Alzheimer’s disease, obsessive compulsive disorder and addiction. This project was supported by the International Neuromodulation Society.

  • Reply to

    you whiners

    by sepi9 Jan 20, 2015 4:40 PM
    pharmaapproved pharmaapproved Jan 20, 2015 5:14 PM Flag

    I think the sting is in the timing. There are a lot of posters here who said, "there would be no secondary for years if ever." Those posters where saying Arena had enough cash, or, would have a partner w/cash for drugs in the pipeline. Ehhhhh,, neither happened before hitting shareholders once again. This company could care less about shareholders, and I'm glad I figured it out. The pipeline although promising is no slam dunk! I was really considering putting money to work here just this past Friday. So glad I didn't!! I really feel bad for those stuck here for years to only get s(h)i)(t) on once again! Pathetic is being to kind!!!!

  • Reply to

    Bariatric surgery IS tax deductible

    by flythink222 Jan 20, 2015 2:10 PM
    pharmaapproved pharmaapproved Jan 20, 2015 2:14 PM Flag

    That is explained in this link along with other valuable information.


  • pharmaapproved pharmaapproved Jan 20, 2015 2:07 PM Flag

    Everyone should review the whole site. Very informative and will answer a lot of your questions regarding reimbursement, who pays here in the U.S, Australia and what options are available.


  • pharmaapproved pharmaapproved Jan 20, 2015 1:33 PM Flag

    Provider coverage will be a slow process, always has been. However, Vbloc couldn't have hit the market at a better time. With obesity being classified as a disease, and the appointment of "Vivek Murthy New Surgeon General" who has made obesity a top priority of his, there will be quicker adoption to treatment coverage than in the past. There already is!

    However, did you know 80% of obesity surgeries performed to date have been from self pay patients. That's right, no different than going to the dentist, or having any other surgery for that matter where patients pay their own bills. There will be several payment options for patients which ETRM has been playing an active roll in for several months anticipating FDA approval. Options will include, credit card, third party lenders, and in-house financing ect.......

    As far as the data you mentioned in this thread. You can spit the data anyway you want it. ETRM got FDA approval for a reason you obviously haven't figured out. You really think if there was weak data the FDA would let Doctors cut on you implanting a device? You're starting to sound as silly as the old bashers who said "we wouldn't get a favorable panel opinion or FDA Approval"

    As far as partner. Early stage Medical Device companies don't partner, they get bought out!

  • Reply to

    Stock will stay LOW until Revenues start

    by warren06 Jan 16, 2015 10:24 PM
    pharmaapproved pharmaapproved Jan 19, 2015 9:53 AM Flag

    Warren, About Australia and your timeline.

    Knudson was asked "Could you potentially launch in Australia in early 2015."

    Knudson replied "That is something we will know within the next quarter, quarter in a half.
    the FDA approval has been very much a factor as far as reimbursement in Australia, why I don't know, but it has been. But we are prepared now to move along and get that set up in Australia. We have dramatically curtailed any spending in Australia as we get through FDA approval"

    This sounds to me if US approval is given Australia will be back on track immediately.
    ETRM BOD - Anthony P. Jansz

    Anthony P. Jansz has served as one of our directors since May 2011. Mr. Jansz served as Chairman of the Australian Institute of Weight Control (AIWC), the largest network of bariatric surgery clinics in Australia and a collaboration partner with respect to our commercialization efforts in Australia, from 2008 to March 2011. Mr. Jansz is also a director and shareholder of IWC, the Sydney based clinic of the AIWC, and a director and major shareholder of The Medical Finance Company, which provides finance programs for patients undertaking bariatric procedures in Australia.

  • Reply to

    My gut feeling

    by zeeman123456 Jan 17, 2015 10:29 AM
    pharmaapproved pharmaapproved Jan 18, 2015 11:06 AM Flag

    I wouldn't be surprised with a buy-out, but I would be very disappointed with $2.50
    Surly they can get a better deal than what was made between Medtronic and Transneuronix which we all know ended in a fiasco. One, we have an approved device, two, what is $300 mil today compared to what it was in 2005

  • Reply to

    Out of Pocket costs.

    by brass22001 Jan 18, 2015 8:55 AM
    pharmaapproved pharmaapproved Jan 18, 2015 10:41 AM Flag

    You are not considering the fact there will be options. Credit cards, third-party lenders ect........

  • Reply to

    Question if you know

    by pharmaapproved Jan 17, 2015 3:48 PM
    pharmaapproved pharmaapproved Jan 18, 2015 10:35 AM Flag

    I was always under the impression if you're disabled which can happen at any age and you're collecting SSD you are automatically are covered by Medicare.

  • Reply to

    Question if you know

    by pharmaapproved Jan 17, 2015 3:48 PM
    pharmaapproved pharmaapproved Jan 17, 2015 6:42 PM Flag

    Thanks for your input. I guess my original thinking was "exploring" could mean a couple of different approaches, but you're probably right. The reason I asked was because of a remark made by Greg Lea.

    "The company has begun negotiations with private insurers, and the device has been recognized as exploratory by the board that sets policy for Medicare reimbursements, and Lea expressed hope that some might agree to cover the procedure as early as later this year."

  • pharmaapproved by pharmaapproved Jan 17, 2015 3:48 PM Flag

    The device has been recognized as “exploratory” by the board that sets policy for Medicare reimbursements.

    Does it mean they are exploring whether to cover the cost?
    Does it mean they are exploring with a "limited" amount of patients to see if it's worth covering or not?

  • pharmaapproved pharmaapproved Jan 16, 2015 8:29 PM Flag

    Maybe you need to go read their sec filings.

11.515-0.065(-0.56%)3:41 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.